P.P. Power
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Vibrio bacteria research studies
- Enterobacteriaceae and Cronobacter Research
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 48
-
- Infections and bacterial resistance 9
- Vibrio bacteria research studies 8
- Enterobacteriaceae and Cronobacter Research 5
- Co-authors
- Gabriel Gutkind (41 shared papers)Juan A. Ayala (9 shared papers)Marcela Rádice (10 shared papers)Moreno Galleni (16 shared papers)José Di Conza (9 shared papers)M.M. Rodríguez (12 shared papers)Marta Mollerach (3 shared papers)Àngela Famiglietti (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (20 papers)Microbial Drug Resistance (3 papers)Current Pharmaceutical Design (3 papers)Journal of Clinical Microbiology (2 papers)International Journal of Antimicrobial Agents (2 papers)
- Partner nations
- ArgentinaBelgiumUnited States
In The Last Decade
P.P. Power
56 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 76
- Molecular Medicine 736
- Endocrinology 348
- Applied Microbiology and Biotechnology 38
- Pollution 171
- Pharmacology 153
Countries citing papers authored by P.P. Power
This map shows the geographic impact of P.P. Power's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.P. Power with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.P. Power more than expected).
Fields of papers citing papers by P.P. Power
This network shows the impact of papers produced by P.P. Power. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.P. Power. The network helps show where P.P. Power may publish in the future.
Co-authors
The 25 scholars most cited alongside P.P. Power, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 113 | |
| 2 | 2002 | 86 | |
| 3 | 2012 | 69 | |
| 4 | 2005 | 52 | |
| 5 | 2009 | 40 | |
| 6 | 2001 | 40 | |
| 7 | 2011 | 39 | |
| 8 | 1991 | 39 | |
| 9 | 2005 | 36 | |
| 10 | 1999 | 32 | |
| 11 | 2006 | 32 | |
| 12 | 2001 | 32 | |
| 13 | 2016 | 25 | |
| 14 | 2007 | 24 | |
| 15 | [Genetic environment of CTX-M-2 in Klebsiella pneumoniae isolates from hospitalized patients in Uruguay]. | 2006 | 23 |
| 16 | 2013 | 20 | |
| 17 | 2008 | 20 | |
| 18 | 2019 | 19 | |
| 19 | 2006 | 19 | |
| 20 | 2021 | 18 |
About P.P. Power
P.P. Power is a scholar working on Molecular Medicine, Endocrinology, Molecular Biology, Pharmacology and Epidemiology, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (48 papers), Antibiotics Pharmacokinetics and Efficacy (14 papers), Bacterial biofilms and quorum sensing (12 papers), Infections and bacterial resistance (9 papers), Vibrio bacteria research studies (8 papers), Pneumonia and Respiratory Infections (8 papers), Pharmaceutical and Antibiotic Environmental Impacts (6 papers) and Enterobacteriaceae and Cronobacter Research (5 papers). The work is most often cited by research in Molecular Medicine (736 citations), Endocrinology (348 citations), Applied Microbiology and Biotechnology (38 citations), Pollution (171 citations) and Pharmacology (153 citations). P.P. Power has collaborated with scholars based in Argentina, Belgium and United States. Frequent co-authors include Gabriel Gutkind, Juan A. Ayala, Marcela Rádice, Moreno Galleni, José Di Conza, M.M. Rodríguez, Marta Mollerach, Àngela Famiglietti, Carlos Vay and Renaud Berlemont. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Microbial Drug Resistance, Current Pharmaceutical Design, Journal of Clinical Microbiology and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.